Sign in

Jaakko Sarparanta

@jaakkosarparanta.bsky.social
185 followers 92 following 8 posts

Molecular biologist studying neuromuscular disease in the Myofin group (@myofinlab.bsky.social) at Folkhälsan Research Center (@folkhalsanresearch.bsky.social), Helsinki, Finland.

PostsRepliesMedia
Jaakko Sarparanta @jaakkosarparanta.bsky.social · 26/07/2026
#Finlandiahall, the venue for #WMS2027 has been inscribed on the UNESCO World Heritage List as a part of the #AaltoWorks entity. Another great reason to attend the @worldmusclesociety.org congress in Helsinki next year! whc.unesco.org/en/newproper...
whc.unesco.org
010
Reposted by Jaakko Sarparanta
Myofin Research Group @myofinlab.bsky.social · 28/02/2026
Today is Rare Disease Day. 🩷💚💙💜 Approximately 5% of the world's population is affected by a rare disease. #RareDiseaseDay is an important initiative for us, as nearly 90% of neuromuscular disorders are classified as rare diseases. (1/5) @rarediseaseday.bsky.social
154
Reposted by Jaakko Sarparanta
Myofin Research Group @myofinlab.bsky.social · 04/12/2025
🚨Publication alert!🚨 First author @jaakkosarparanta.bsky.social ’s summary of the article: (1/5)
academic.oup.com
C-terminal extension of HSPB6 in a family with myopathy and cataract
Abstract. The small heat shock protein HSPB6 (a.k.a. Hsp20) is highly expressed in striated and smooth muscles. It modulates the oligomerization of its par
142
Reposted by Jaakko Sarparanta
Myofin Research Group @myofinlab.bsky.social · 20/11/2025
🚨Publication alert!🚨 First author Veronica's summary of the article: "The study focused on finding a robust and reproducible method to differentiate the C2C12 murine myoblast into mature and functional myotubes in a 2D culture system." (1/3)
link.springer.com
Optimizing 2D in vitro differentiation conditions for C2C12 murine myoblasts on gelatin hydrogel - Journal of Muscle Research and Cell Motility
Optimizing in vitro differentiation protocols for skeletal muscle cells is essential for producing mature, functional myotubes suitable for disease modeling and therapeutic screening. While C2C12 muri...
132
Jaakko Sarparanta @jaakkosarparanta.bsky.social · 11/10/2025
Homeward bound from #WMS2025. I guess next year flying will be unavoidable.
040
Jaakko Sarparanta @jaakkosarparanta.bsky.social · 10/10/2025
Come and meet me at my poster (700P) in #WMS2025, today 14:15–15:15. Also other posters from @myofinlab.bsky.social presented during the same session!
020
Jaakko Sarparanta @jaakkosarparanta.bsky.social · 06/10/2025
After a delay and rerouting, the journey towards #WMS2025 continues: Hamburg – Würzburg – Vienna.
Railways seen from a train window.
020
Jaakko Sarparanta @jaakkosarparanta.bsky.social · 05/10/2025
After a lazy day is Stockholm (Fotografiska never fails!), the next leg towards #WMS2025 in Vienna: SJ EuroNight Stockholm–Hamburg.
A couchette car on a night train.
020
Jaakko Sarparanta @jaakkosarparanta.bsky.social · 04/10/2025
Starting my voyage towards Vienna and #WMS2025 on the Helsinki–Stockholm ferry.
Helsinki south harbour and cathedral from the sea.
021
Jaakko Sarparanta @jaakkosarparanta.bsky.social · 28/09/2025
Two years from today #Helsinki and #Finlandiahall will welcome #WMS2027, the annual congress of @worldmusclesociety.org. Save the date!
043
Jaakko Sarparanta @jaakkosarparanta.bsky.social · 23/09/2025
Meet me at my poster today at #EMC2025!
020
Reposted by Jaakko Sarparanta
Myofin Research Group @myofinlab.bsky.social · 19/09/2025
Our team is excited to connect - come find Jenni, Jaakko and Fanny at the European Muscle Conference. 🇳🇱 Let’s talk science, collaboration, and future ideas! 🧬🤝💡 #EMC2025 #EuropeanMuscleConference
033
Reposted by Jaakko Sarparanta
Michael Wong @miquai.bsky.social · 29/03/2025
I received a heartbreaking email today: A paper in a special issue I’m editing is being retracted because one of its authors is afraid of losing their job and their legal status in the U.S. if they publish a scientific study on evolution. Yes, on evolution, nature's engine of diversity.
10934311312000
Reposted by Jaakko Sarparanta
Myofin Research Group @myofinlab.bsky.social · 28/02/2025
#RareDiseaseDay is on the last day of February (28th or 29th). Approximately 5% of the world's population is affected by a rare disease. Rare Disease Day is an important initiative for us, as nearly 90% of neuromuscular disorders are classified as rare diseases. (1/5)
175